An Isatin β-thiosemicarbazone (IBT)-dependent Mutant of Vaccinia Virus: The Nature of the IBT-dependent Step

References

1. Eagle H. 1959; Amino acid metabolism in mammalian cell cultures. Science, New York 130:432–437
   [Google Scholar]
2. Fairbanks G. Jun, Levinthal G., Reeder R. H. 1965; Analysis of ¹⁴C-labelled proteins by disc electrophoresis. Biochemical and Biophysical Research communications 20:393–399
   [Google Scholar]
3. Holowczak J. A., Joklik W. K. 1967; Studies on the structural proteins of vaccinia virus. I. Structural proteins of virions and cores. Virology 33:717–725
   [Google Scholar]
4. Joklik W. K., Becker Y. 1964; The replication and coating of vaccinia DNA. Journal of Molecular Biology 10:452–474
   [Google Scholar]
5. Katz E., Margalith E., Winer B., Goldblum N. 1973a; Synthesis of vaccinia viral polypeptides in the presence of isatin P thiosemicarbazone. Antimicrobial Agents and Chemotherapy 4:44–48
   [Google Scholar]
6. Katz E., Moss B. 1970a; Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin. Proceedings of the National Academy of Sciences of the United States of America 66:677–684
   [Google Scholar]
7. Katz E., Moss B. 1970b; Vaccinia virus structural polypeptide derived from a high molecular weight precursor: formation and integration into virus particles. Journal of Virology 6:717–726
   [Google Scholar]
8. Katz E., Winer B., Margalith E., Goldblum N. 1973b; Isolation and characterization of an IBT-dependent mutant of vaccinia virus. Journal of General Virology 19:161–164
   [Google Scholar]
9. Moss B. 1968; Inhibition of HeLa cell protein synthesis by the vaccinia virion. Journal of Virology 2:1028–1037
   [Google Scholar]
10. Moss B., Rosenblum E. N., Katz E., Grimley P. M. 1969; Rifampicin - a specific inhibitor of vaccinia virus assembly. Nature, London 224:1280–1284
    [Google Scholar]
11. Moss B., Salzman N. P. 1968; Sequential protein synthesis following vaccinia virus infection. Journal of Virology 2:1016–1027
    [Google Scholar]
12. Salzman N. P. 1960; The rate of formation of vaccinia deoxyribonucleic acid and vaccinia virus. Virology 10:150–152
    [Google Scholar]
13. Salzman N. P., Sebring E. D. 1967; Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid replication. Journal of Virology 1:16–23
    [Google Scholar]
14. Shatkin A. J. 1963; Actinomycin D and vaccinia virus infection of HeLa cells. Nature, London 199:357–358
    [Google Scholar]
15. Sheffield F. W., Bauer D. J., Stephenson S. 1960; The protection of tissue cultures by isatin β thiosemi-carbazone from the cytopathic effects of certain pox viruses. British Journal of Experimental Pathology 41:638–647
    [Google Scholar]
16. Summers D. F., Maizel J. V., Darnell J. E. Jr 1965; Evidence for virus specific non-capsid proteins in poliovirus infected HeLa cells. Proceedings of the National Academy of Sciences of the United States of America 54:505–513
    [Google Scholar]
17. Woodson B., Joklik W. K. 1965; The inhibition of vaccinia virus multiplication by isatin β thiosemi-carbazone. Proceedings of the National Academy of Sciences of the United States of America 54:946–953
    [Google Scholar]
18. Zylber E. A., Penman S. 1970; The effect of high ionic strength on monomers, polyribosomes and puromycin-treated polyribosomes. Biochimica et biophysica acta 204:221–229
    [Google Scholar]